Point72 Asset Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
JCM
Point72 Asset Management's CDLX Position: Q1 2022 in Review
Point72 Asset Management sold out of Cardlytics (CDLX) in Q1 2022, closing a stake of 1,040 shares — an estimated $687K sold.
Point72 Asset Management first reported a position in CDLX in Q3 2020 and held it in 2 quarters. The position peaked at $1.58M in Q3 2020. 153 funds tracked by Wall St. Rank hold CDLX as of Q1 2022.
- Point72 Asset Management reported no remaining Cardlytics position as of Q1 2022 after selling out during the quarter.
- Point72 Asset Management sold 1,040 Cardlytics shares in Q1 2022, an estimated $687K.
- Point72 Asset Management first reported a position in Cardlytics in Q3 2020 and held it in 2 quarters.
- Point72 Asset Management's Cardlytics position peaked at $1.58M in Q3 2020.
- 153 funds tracked by Wall St. Rank held Cardlytics as of Q1 2022.
Based on Point72 Asset Management's 13F filing for Q1 2022, filed 16 May 2022.